ICON Accelerates Site Activation Timelines by up to 25%
ICON announce that it has accelerated its study start-up timelines globally and has achieved a reduction of mean start-up cycle times by up to 25%
ICON Acquires PMG Research Inc.
Acquisition enhances ICON’s site and patient engagement capabilities
ICON Partners with iCardiac Technologies
The partnership aims to provide an earlier and more precise method for evaluating cardiac safety.
ICON Reports Third Quarter 2015
In the third quarter net revenue grew 1.8% year on year to $394.7 million.
ICON Strengthens its Leadership Team in Asia Pacific with Two Key Appointments
Mary Pan is new VP of Asia Pacific and Hiroshi Ichikawa leads ICON’s operations in Japan.
ICON Receives Finalist Nomination for the 2015 Scrip Awards
Firecrest eConsent shortlisted in best technological development in Clinical Trials category.
ICON and IBM to Revolutionise Clinical Trials
ICON applies IBM Watson clinical trial matching to oncology clinical trials.
ICON Launches Medical Device & Diagnostics Research Group
Dedicated services to support medical device manufacturers throughout the product lifecycle.
ICON Completes Acquisition of MediMedia Pharma Solutions
Extends ICON’s leadership in commercialisation and market access services and brings new scientific communications capabilities
ICON Launches Electronic Informed Consent
Part of ICONIK Informatics Hub to enhance patient engagement in the trial process, in line with FDA guidelines.